Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01655576
Other study ID # PLADRAINAGE
Secondary ID Pla1
Status Completed
Phase N/A
First received July 31, 2012
Last updated June 4, 2013
Start date August 2012
Est. completion date May 2013

Study information

Verified date July 2012
Source Instituto Materno Infantil Prof. Fernando Figueira
Contact n/a
Is FDA regulated No
Health authority Brazil: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if placental drainage shortens third period of labor and reduces postpartum blood lost.


Description:

The study aims to compare the effectiveness of placental drainage versus maintenance of maternal cord clamped end in the third stage of labor to reduce postpartum blood loss.


Recruitment information / eligibility

Status Completed
Enrollment 226
Est. completion date May 2013
Est. primary completion date May 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Low risk pregnant women

- Pregnancy at term

- Women at low risk for assisted labor / delivery and postpartum care.

- Live Fetus

Exclusion Criteria:

- Women under 18, mentally handicapped and indigenous;

- Women who agreed to participate signed the Informed Consent, but evolved to cesarean section or instrumental delivery by forceps;

- Instrumental Delivery by forceps or c-section

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Placental drainage
After delivery of the newborn, umbilical cord at mothers end, will be left unclamped until delivery of the placenta.

Locations

Country Name City State
Brazil IMIP Recife Pernambuco

Sponsors (1)

Lead Sponsor Collaborator
Instituto Materno Infantil Prof. Fernando Figueira

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Duration of the third period of labor Time from delivery of the baby to the delivery of the placenta Six hours No
Secondary Postpartum blood loss Volume of blood lost 24 hours after birth 24 hours No
Secondary PPH Postpartum hemorrhage 24 hours No
Secondary Need of uterotonics use of aditional uterotonics ( prophylkatic use not included) 24 hours No
Secondary Need of blood transfusions Need of blood transfusions until discharge No